Inventor · disambiguated record
Suresh B. Singh
Also filed as: SINGH SURESH · SINGH SURESH B
69 granted patents·22 pending applications·355 citations·filing 2005–2025
99Inventor score
Files withVITAE PHARMACEUTICALS INC31CLAREMON DAVID A19VITAE PHARMACEUTICALS LLC19BALDWIN JOHN J12CACATIAN SALVACION3
Top patents by PatentIndex Score
91 records- 0195US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0295US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0395US8242111B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Aug 14, 2012·36 cites·24 claims
- 0495US8138178B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 20, 2012·37 cites·24 claims
- 0594US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0694US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0793US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0893US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 0993US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1092US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 1192US8202857B21,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Jun 19, 2012·21 cites·75 claims
- 1291US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 1391US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 1491US8981112B2Inhibitors of β-secretaseBOEHRINGER INGELHEIM INT·Filed 2013·Granted Mar 17, 2015·14 cites·17 claims
- 1591US8440658B2Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted May 14, 2013·16 cites·19 claims
- 1689US7858624B2Piperidine and morpholine renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Dec 28, 2010·7 cites·4 claims
- 1789US7754737B2Diaminoalkane aspartic protease inhibitorsVITAE PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·16 cites·10 claims
- 1888US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 1988US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 2088US7872028B2Diaminopropanol renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Jan 18, 2011·14 cites·10 claims
- 2187US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 2286US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2386US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 2485US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 2585US8633212B2Inhibitors of beta-secretaseCACATIAN SALVACION·Filed 2010·Granted Jan 21, 2014·10 cites·22 claims
- 2684US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 2783US8575156B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Nov 5, 2013·5 cites·20 claims
- 2882US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 2982US8569292B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Oct 29, 2013·5 cites·7 claims
- 3080US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 3180US8598160B2Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Dec 3, 2013·4 cites·15 claims
- 3280US8592410B2Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Nov 26, 2013·4 cites·10 claims
- 3379US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 3479US8198453B2Piperidine renin inhibitorsBALDWIN JOHN J·Filed 2007·Granted Jun 12, 2012·3 cites·3 claims
- 3578US8680281B2Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 25, 2014·3 cites·15 claims
- 3678US8383629B2Inhibitors of 11β-hydroxysteroid dehydrogenase type 1VITAE PHARMACEUTICALS INC·Filed 2009·Granted Feb 26, 2013·3 cites·27 claims
- 3778US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 3877US10829481B2Benzimidazole derivatives as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Nov 10, 2020·1 cites·22 claims
- 3977US8673899B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2012·Granted Mar 18, 2014·3 cites·22 claims
- 4076US8598163B2Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disordersCLAREMON DAVID·Filed 2010·Granted Dec 3, 2013·6 cites·30 claims
- 4175US9949975B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·1 cites·4 claims
- 4275US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
- 4375US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 4473US8399504B2Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 19, 2013·1 cites·24 claims
- 4572US11008340B2Modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 18, 2021·1 cites·14 claims
- 4672US9388190B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·1 cites·16 claims
- 4772US9018391B2Inhibitors of beta-secretaseBUKHTIYAROV YURI·Filed 2013·Granted Apr 28, 2015·2 cites·38 claims
- 4871US9526727B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·12 claims
- 4971US9045500B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jun 2, 2015·1 cites·10 claims
- 5071US8835426B2Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Sep 16, 2014·1 cites·15 claims
Showing the top 50 of 91 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Suresh B. Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →